Day, welcome to the AdaptHealth Corp Annual Meeting of Stockholders. I would now like to turn the conference over to Suzanne Foster. Please go ahead. Thank you, good morning. I am Suzanne Foster, Chief Executive Officer of AdaptHealth Corp. It is a pleasure to welcome you to our Annual Meeting of Stockholders. This meeting is now called to order. On behalf of our directors, officers, and employees, I want to thank you for joining us at our virtual annual meeting of our stockholders. We are holding this meeting virtually to maximize shareholder participation. Following the official items of business, we will answer questions submitted on the website. If you have logged into the meeting with your control number, you may ask a question by typing it into the box at the bottom of the screen any time during this meeting. Before we begin, I would like to thank Rob Capriotti from KPMG and the members of our board of directors, including our chairman, Dale Wolf, for participating in today's call. At this time, I'd like to turn the floor over to Richard Rew, our Chief Legal Officer, General Counsel and Secretary, for the procedural matters of this meeting. Thank you, Suzanne. Turning to the procedural matters and the formal business of the meeting, please note the record date for the meeting was April 24th, 2026. Only stockholders of record on the close of business on that date are entitled to vote and submit questions at this meeting. The proxy materials were first mailed on or about April 28th, 2026 to all stockholders of record and will be maintained with the minutes of this meeting. Lou Larson has been appointed as the Inspector of Elections for the meeting, and he has signed an oath of office, which is available for your examination and will be filed with the minutes of this meeting. I will serve as Secretary for purposes of this meeting. We have present online or by proxy a sufficient number of shares to constitute a quorum, so the meeting is duly constituted. I have been authorized by the board to hold and act upon proxies solicited and received by the company, AdaptHealth, in connection with this meeting. We will vote by proxy and by electronic ballot today. If you have voted by internet or telephone or sent in your proxy card and do not intend to change your vote, then it is not necessary that you vote because we will count your proxy. If you have not yet submitted a proxy card and wish to vote on these items or wish to revoke a proxy card you have previously signed, you may vote your shares by clicking on the Vote Here button on your screen now. You will need the control number provided on your proxy in order to vote your shares online. The polls are now open. Turning to the formal business of the meeting, as described in the proxy materials, there are three items on today's agenda. Each of these items has been described in the proxy materials previously delivered to all stockholders of record for this meeting. As noted in the agenda, there will be a period following formal adjournment of the meeting for questions. If you have a question, please submit it through the virtual meeting platform. Once again, if you have logged into the meeting with your control number and would like to ask a question, you may do so by typing your question in the box at the bottom of the screen. We will prioritize questions that relate to proposals considered at this meeting. If you have general questions about AdaptHealth, please include your contact information so we can respond directly to you after the meeting. The first item on which we are voting today is to elect nine directors: Gregory Belinfanti, Terence Connors, Brad Coppens, Suzanne Foster, Ted Lundberg, Kenneth A. Samet, Dr. Susan Weaver, David Williams III, and Dale Wolf to serve for a one-year term expiring at our 2027 annual meeting of stockholders. The second item on which we are voting today is to ratify the appointment of KPMG LLP as AdaptHealth's independent registered public accounting firm for the fiscal year ending December 31, 2026. The third item on which we are voting today is approval in a non-binding advisory vote of the compensation paid to our named executive officers. For those of you who are voting here, please submit online accordingly and indicate the way you wish to vote. We will now pause to allow stockholders to vote. The polls are now closed. In just a moment, we will report the results of the meeting after we tally the votes. We have completed the tally of the votes. Lou Larson, the Inspector of Elections, will report the results. The preliminary results are as follows. Of the 136,054,152 shares of common stock eligible to vote at this meeting, a total of approximately 120,652,493 shares of common stock were actually present or represented by proxy. This represents approximately 88.67% of the total shares eligible to vote. The first proposal was to approve the election of nine directors to serve on AdaptHealth's board of directors. I hereby declare that each of Gregory Belinfanti, Terence Connors, Brad Coppens, Ted Lundberg, Suzanne Foster, Kenneth A. Samet, Dr. Susan Weaver, David Williams III, and Dale Wolf received the requisite plurality vote, and each is elected for a one-year term expiring at AdaptHealth's 2027 annual meeting. The second proposal was to ratify the selection of KPMG LLP as AdaptHealth's independent registered public accounting firm for the fiscal year ending December 31st, 2026. An aggregate of approximately 99% of the total shares represent and entitled to vote on this proposal at the meeting was voted in favor of this proposal. I hereby declare that the proposal has passed by the necessary vote. The third proposal was a non-binding advisory vote on the compensation paid to our named executive officers. The number of votes in favor of the proposal exceeded the number of votes against the proposal. I hereby declare that the proposal is passed by the necessary vote. Thank you. This brings the formal business portion of the meeting to an end. I would like to thank all the stockholders present online, as well as those who participated by proxy. After adjournment, we will conduct a brief Q&A session to answer questions submitted during the meeting. There being no further business, do I have a motion to adjourn the business portion of this meeting? Moved. Is there a second? Second it. The meeting is adjourned. Thank you for your support and for joining us today. We will now begin the Q&A portion. There are no questions relevant to the meeting, so we are hereby adjourned. Thank you for your participation.